Beyond Air (NASDAQ: XAIR) — Perfil da empresa, notícias e dados financeiros
Beyond Air develops innovative medical devices targeting lung diseases, focusing on Nitric Oxide therapies.
Beyond Air
Beyond Air (NASDAQ:XAIR) is focused on developing innovative medical devices and therapies aimed at transforming treatment options for patients with lung diseases and severe infections. The company has a diverse portfolio of projects, including advanced systems for Nitric Oxide delivery that target a range of medical conditions, from chronic lung infections to certain types of cancer. Beyond Air's objectives are centered around harnessing the therapeutic potential of Nitric Oxide to offer safer, more effective treatments, and improving patient outcomes across the globe. Aiming to push the boundaries of medical science, Beyond Air is committed to research, development, and commercialization of cutting-edge medical technologies.
Resumo
Operações
Produtos e/ou serviços de Beyond Air
- LungFit PH system for generating high concentration nitric oxide (NO) from ambient air for treating various respiratory infections.
- LungFit GO, a portable system for NO therapy in outpatient settings.
- LungFit BRO, designed for the treatment of bronchiolitis in hospitalized infants, using nitric oxide.
- Pipeline development for treating chronic obstructive pulmonary disease (COPD) with nitric oxide therapies.
- Research on high-dose nitric oxide therapy for the treatment of COVID-19.
- Advancements in using nitric oxide for treating nontuberculous mycobacterial (NTM) lung disease.
equipe executiva do Beyond Air
- Robert Scott GoodmanCEO & Director
- Daniel J. MoorheadChief Financial Officer
- Michael A. GaulChief Operating Officer
- Denton DrewellPrincipal Accounting Officer & Controller
- Andrew R. ColinSenior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
- John JettHead of Research & Clinical Development
- Amir AvnielChief Executive Officer of NeuroNOS
- Adam T. NewmanCorporate Secretary
Principais indicadores financeiros
Resultados divulgados pela Beyond Air, em USD.
- Cap. de mercado
- 2,2 mi
- Receita (TTM)
- 7,7 mi
- P/L
- —
- LPA (diluído, TTM)
- -64.4
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 7,7 mi | -29 mi | -33,2 mi | |
| 3,7 mi | -44,5 mi | -46,6 mi | |
| 1,2 mi | -63 mi | -60,2 mi | |
| 59 mil | -52,1 mi | -55,8 mi |